Tumor-Specific T-Cells (cCTL:GL01) for Advanced Gastrointestinal Cancer | MicrobiomeTrials← Back to trialsNCT07735065
Tumor-Specific T-Cells (cCTL:GL01) for Advanced Gastrointestinal Cancer
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-08-01Est. Completion: 2028-08-01
Enrollment target: 20 participants Other microbiome trials you might be interested in
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerHR+/HER2- Ductal and Lobular Breast CancerTriple Negative Breast CancerColorectal Cancer
The purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[177Lu\]Lu-NNS…
Birmingham, United StatesEst. completion Jan 15, 2031
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular Carcinoma
Alpha-fetoprotein (AFP)-Producing Gastric Cancer
Extragonadal Yolk Sac Tumors
Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer
This is a first-in-human (FIH) clinical study designed to evaluate the safety, tolerability, pharmacokinetics (PK), phar…
Goodyear, United StatesEst. completion May 30, 2028